Morpholino

MO2-brca2

ID

ZDB-MRPHLNO-181101-1

Name

MO2-brca2

Previous Names

None

Target

brca2 (1)

Sequence

5' - TTTCAAACATGCTGCCATGAGTGTG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO. There is a mismatch in the published morpholino sequence, the above sequence is correct.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-brca2

Expressed Gene	Anatomy	Figures
nr5a1a	interrenal primordium	Fig. 7 from Kroeger et al., 2017
wt1b	pronephric podocyte	Fig. 7 from Kroeger et al., 2017

Phenotype

Phenotype resulting from MO2-brca2

Phenotype	Fish	Figures
interrenal primordium nr5a1a expression increased amount, abnormal	WT + MO2-brca2	Fig. 7 from Kroeger et al., 2017
interrenal primordium nr5a1a expression increased distribution, abnormal	WT + MO2-brca2	Fig. 7 from Kroeger et al., 2017
interrenal primordium increased size, abnormal	WT + MO2-brca2	Fig. 7 from Kroeger et al., 2017
pronephric glomerulus development decreased occurrence, abnormal	WT + MO2-brca2	Fig. 7 from Kroeger et al., 2017
pronephric podocyte wt1b expression decreased amount, abnormal	WT + MO2-brca2	Fig. 7 from Kroeger et al., 2017
pronephros lacks parts or has fewer parts of type pronephric podocyte, abnormal	WT + MO2-brca2	Fig. 7 from Kroeger et al., 2017

Phenotype of all Fish created by or utilizing MO2-brca2

Phenotype	Fish	Conditions	Figures
pronephric podocyte wt1b expression absent, abnormal	WT + MO2-brca2	chemical treatment by environment: DAPT	Fig. 11 from Kroeger et al., 2017
pronephric glomerulus development decreased occurrence, abnormal	WT + MO2-brca2	standard conditions	Fig. 7 from Kroeger et al., 2017
interrenal primordium nr5a1a expression increased distribution, abnormal	WT + MO2-brca2	chemical treatment by environment: DAPT	Fig. 11 from Kroeger et al., 2017
pronephros lacks parts or has fewer parts of type pronephric podocyte, abnormal	WT + MO2-brca2	chemical treatment by environment: DAPT	Fig. 11 from Kroeger et al., 2017
interrenal primordium nr5a1a expression increased distribution, abnormal	WT + MO2-brca2	heat shock	Fig. 11 from Kroeger et al., 2017
pronephric podocyte wt1b expression decreased amount, abnormal	WT + MO2-brca2	standard conditions	Fig. 7 from Kroeger et al., 2017
interrenal primordium nr5a1a expression increased distribution, abnormal	WT + MO2-brca2	standard conditions	Fig. 7 from Kroeger et al., 2017
interrenal primordium nr5a1a expression increased amount, abnormal	WT + MO2-brca2	standard conditions	Fig. 7 from Kroeger et al., 2017
pronephric podocyte wt1b expression absent, abnormal	WT + MO2-brca2	heat shock	Fig. 11 from Kroeger et al., 2017
pronephros lacks parts or has fewer parts of type pronephric podocyte, abnormal	WT + MO2-brca2	heat shock	Fig. 11 from Kroeger et al., 2017
interrenal primordium increased size, abnormal	WT + MO2-brca2	standard conditions	Fig. 7 from Kroeger et al., 2017
pronephros lacks parts or has fewer parts of type pronephric podocyte, abnormal	WT + MO2-brca2	standard conditions	Fig. 7 from Kroeger et al., 2017
pronephric podocyte wt1b expression absent, abnormal	kca3Tg; kca4Tg + MO2-brca2	heat shock	Fig. 11 from Kroeger et al., 2017
interrenal primordium nr5a1a expression spatial pattern, ameliorated	kca3Tg; kca4Tg + MO2-brca2	heat shock	Fig. 11 from Kroeger et al., 2017
pronephros lacks parts or has fewer parts of type pronephric podocyte, abnormal	kca3Tg; kca4Tg + MO2-brca2	heat shock	Fig. 11 from Kroeger et al., 2017

Citations